DOI: 10.36347/sasjm.2021.v07i07.003

Pages: 309-312

It’s is primary or secondary malignant neoformations developed at the expense of the structures of the pancreas. Most pancreatic cancers are damage to its exocrine unit: more than 90%against 5 to 10% of islet tumors and they occur twice as often in the head of the pancreas than in the body or of the tail. Cancer is responsible for 9 million deaths each year, the disease is thought to affect 17, 5 million people worldwide. In Mali, Pancreatic cancer accounts for 1, 7 and 0, 8 percent of all cancers in men and women respectively; the five-year survival rate is between1and 10 percent although the diagnosis seems straightforward. However the big one majority of cases are seen at an advanced stage. This gloomy prognosis is to a large extent also linked to the clinical latency not allowing to make the diagnosis at the initial stage of the disease. Ductal adenocarcinoma appears to be the most common 80 percent. Pancreatic endocrine tumors arouse gret interest because of their physiopathological and prognostic characteristics, a heterogeneous evolutionary potential. This condition has been very little studied in Mali.